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Abstract
Background: Surgery, Antibiotics, Facial cleanliness and Environmental improvement (SAFE) are advocated by the World
Health Organization (WHO) for trachoma control. However, few studies have evaluated the complete SAFE strategy, and of
these, none have investigated the associations of Antibiotics, Facial cleanliness, and Environmental improvement (A,F,E)
interventions and active trachoma. We aimed to investigate associations between active trachoma and A,F,E interventions
in communities in Southern Sudan.
Methods and Findings: Surveys were undertaken in four districts after 3 years of implementation of the SAFE strategy.
Children aged 1–9 years were examined for trachoma and uptake of SAFE assessed through interviews and observations.
Using ordinal logistic regression, associations between signs of active trachoma and A,F,E interventions were explored.
Trachomatous inflammation-intense (TI) was considered more severe than trachomatous inflammation-follicular (TF). A total
of 1,712 children from 25 clusters (villages) were included in the analysis. Overall uptake of A,F,E interventions was: 53.0% of
the eligible children had received at least one treatment with azithromycin; 62.4% children had a clean face on examination;
72.5% households reported washing faces of children two or more times a day; 73.1% households had received health
education; 44.4% of households had water accessible within 30 minutes; and 6.3% households had pit latrines. Adjusting for
age, sex, and district baseline prevalence of active trachoma, factors independently associated with reduced odds of a more
severe active trachoma sign were: receiving three treatments with azithromycin (odds ratio [OR]=0.1; 95% confidence
interval [CI] 0.0–0.4); clean face (OR=0.3; 95% CI 0.2–0.4); washing faces of children three or more times daily (OR=0.4; 95%
CI 0.3–0.7); and presence and use of a pit latrine in the household (OR=0.4; 95% CI 0.2–0.9).
Conclusion: Analysis of associations between the A,F,E components of the SAFE strategy and active trachoma showed
independent protective effects against active trachoma of mass systemic azithromycin treatment, facial cleanliness, face
washing, and use of pit latrines in the household. This strongly argues for continued use of all the components of the SAFE
strategy together.
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Introduction
The World Health Organization (WHO) promotes the SAFE
strategy for trachoma control (Box 1) which comprises: 1) Surgery,
eyelid surgery to correct in-turned eyelashes that stops pain and
minimizes risk of corneal damage [1]; 2) Antibiotics, treatment for
active trachoma using single-dose oral azithromycin or tetracycline
eye ointment [2]; 3) Facial cleanliness, clean faces especially in
children through sustained behaviour change [3]; and 4) Environ-
mental improvement, to increase access to water and sanitation [4].
Antibiotic therapy in individuals and facial cleanliness in children,
combined with environmental improvement (A,F,E components of
SAFE), have been designed to treat ocular Chlamydia infection and
reduce the risk of transmission of ocular Chlamydia.
There is evidence from randomised controlled trials that the
individual A,F,E components of the SAFE strategy have an effect
on active trachoma when applied on their own: effect of antibiotics
on active trachoma at three months [2]; effect of face-washing on
trachomatous inflammation-intense (TI) [3]; and effect of fly-
control on active trachoma at three and six months [5,6]. In these
trials, the effects of these components have been tested individually
to avoid the use of hybrid interventions that generate findings that
are difficult to interpret. The challenge of disentangling the
relative contribution to an effect of a combination of components
has prevented trials of such hybrid trials being conducted.
However, the reality of program implementation is that SAFE is
a comprehensive and integrated strategy that has three control
components (the A,F,E) that should be applied simultaneously.
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expect there to be an additive effect of the A,F,E components of the
SAFE strategy. Mass azithromycin administration, plus an increase
in clean faces among children, plus improved access to water, plus
reduced vector populations will likely be more effective than any one
component alone. Despite the need for evaluation of the combined
effects of A,F,E components of SAFE being highlighted previously
[7], no studies have explored the relationship between programme
delivery of the combined A,F,E interventions and prevalence of
active trachoma. Therefore we aimed to investigate the association
between active trachoma and community intervention with A,F,E
components of the SAFE strategy.
Methods
Study population
Surveys were conducted in four districts (Kiech Kuon, Padak,
Katigiri and Tali) in Southern Sudan between April to June 2005.
The sample size estimation and sampling of the surveys has been
described previously [8]. In brief, population based surveys were
undertaken to estimate the prevalence of active trachoma signs
before and following three years of implementation of the SAFE
strategy. A two-stage cluster random sampling design was used to
select the sample. In each district, 6 villages (clusters) were selected
in stage one and 30 households selected in each cluster at the
second stage. All eligible persons residing in the household were
examined for trachoma and/ or interviewed. Only children aged
1–9 years, who had been examined for trachoma signs, were
included in the sample (Figure 1).
Outcomes: Severity of active trachoma signs
Eligible children were examined for trachoma signs by integrated
eye care workers (IECW) using the WHO simplified grading scheme
[9]. Trainee examiners had to achieve at least 80% interobserver
agreement in identifying trachoma signs compared to the senior
examiner to participate in the survey [10]. Clinical signs of
inflammatory trachoma (TF, and TI) were graded for each eye
separately. An ordinal severity score of active trachoma comprising
threecategorieswasthenassignedtoalleligibleparticipantsbasedon
the worst affected eye: where ‘1’ was no TF, no TI; ‘2’ TF only; and
‘3’ TI with or without TF. We have previously justified the ordinal
nature of inflammatory signs of trachoma [11]: 1) pathogenesis of
trachoma is initially characterised by lymphoid follicles (stage TF),
whereas papillary hypertrophy (stage TI) is seen with advancing
severity [12]; 2) participants seen in longitudinal studies with
persistent TI are more likely to progress to scarring (stage TS) than
thosewithonlyTF[13];3)subjectswithTIaremorelikelytoprovide
ocular swabs positive for Chlamydia trachomatis than those with TF
[14];and4)patientswithTIprovideocularswabsthathaveagreater
quantifiable load of C. trachomatis than those with TF [15,16].
Interventions: Surgery, Antibiotics, Facial cleanliness and
Environmental improvement (SAFE)
Prior to implementation of the trachoma control programme,
baseline surveys were conducted to establish the need for
interventions and to define programme targets [17]. The SAFE
strategy was implemented in accordance with standards advocated
by the WHO [18–21] and have been described previously [8].
Non-governmental organizations (NGOs) responsible for imple-
menting healthcare, in the absence of Ministry of Health
infrastructure, undertook implementation of the SAFE strategy.
Surgery: Identification and screening of trachomatous trichiasis
(TT) cases was conducted by community health workers trained in
using the WHO simplified grading scheme [9]. TT surgeons were
trained by an experienced ophthalmologist from the Christoffel
Blindenmission (CBM). Eyelid surgery was conducted using the
bilamellar tarsal rotation procedure at primary health care centers
(PHCC) and at annual ‘‘surgery camps’’ [18]. TT surgery logs
were maintained at the PHCC. Trichiasis surgery is not
considered further in this study of associations between A,F,E
interventions and active trachoma.
Antibiotics: Azithromycin (Zithromax, donated by Pfizer) was
targeted for distribution to all villages in the four districts [19].
During the annual treatment round, teams of distributors
including health care workers and trained village volunteer moved
from village to village providing directly observed treatment to all
eligible persons. Persons not eligible to receive Zithromax were
treated with 1% tetracycline eye ointment. A tally of number of
people treated with Zithromax was maintained and reported to
the programme monthly. Three annual rounds were distributed in
Kiech Kuon, Katigiri and Tali; however, the third round had not
been distributed in Padak by the time of the evaluation survey.
Facial cleanliness: Health education and hygiene promotion on
facial cleanliness was conducted by trained hygiene promoters,
women-peer educators and health workers A flip chart with key
messages on facial hygiene and prevention of trachoma was used
routinely to deliver health education at health facilities, schools,
churches and during community outreach. Within villages, trained
women peer-educators coordinated facial hygiene promotion
activities. Heath education was delivered at least once a month
Author Summary
Trachoma is an infectious disease that is cased by a
bacterium, Chlamydia trachomatis, and is the leading cause
of preventable blindness estimated to be responsible for
3.6% of blindness globally. The World Health Organization
(WHO) recommends a strategy for trachoma control
known as SAFE—surgery, antibiotics, facial cleanliness,
and environmental improvement. Regular evaluations of
trachoma control activities are advocated for by the WHO
for decision making, programme planning, and the
rational use of programme resources. We undertook a
survey to evaluate the effectiveness of the SAFE strategy
following three years of interventions in four districts in
Southern Sudan. In this paper, we aimed to find out the
relationship between the antibiotics, facial cleanliness, and
environmental improvement (A,F,E) and active trachoma
signs. Our study revealed that prevalence of active
trachoma was less in children who had received treatment
with azithromycin, had clean faces, had faces washed more
frequently, and used latrines compared to children who
had not received these interventions. The study findings
are important since they make the case for implementing
the A,F,E interventions together.
Box 1. The SAFE strategy for trachoma control
N Surgery: eyelid surgery for the in-turned eyelashes to
stop the pain and minimize risk of corneal damage.
N Antibiotics: treatment for active trachoma using single-
dose oral azithromycin (Zithromax) and tetracycline eye
ointment.
N Facial cleanliness: clean faces especially in children
through sustained hygiene behaviour change.
N Environmental improvement: to increase access to water
and sanitation.
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promotion activities were monitored and reported monthly.
Environmental change: Hygiene promoters and local leaders
spearheaded community mobilization for construction of house-
hold pit latrines. The programme provided digging tools and
technical advice on pit latrine construction. In two districts (Tali
and Katigiri) fero-reinforced concrete slabs were provided free of
charge to households for latrine construction. The number of
latrines constructed was reported monthly. Advocacy for water
provision to target populations by development NGOs involved in
water activities was also conducted.
Measurement of uptake of A,F,E Interventions
Structured interviews with mothers of children as principal
household respondents and observations were used to measure the
uptake of the A,F,E interventions using the following definitions.
Antibiotics: reports by care-givers of the number of times
azithromycin treatment a child had received over three years.
Facial cleanliness: a clean face was defined as the absence of
nasal and/or ocular discharge on examination; frequency of face
washing was reported by care-givers as the number of times faces
of children were washed per day; and whether heads of households
had received health education on trachoma at home or elsewhere.
Environmental improvement: water access was report by people
responsible for water collection as the time for a return journey to
collect water; and pit latrine availability and use was ascertained
by observation.
Other explanatory variables included age, sex, cattle ownership
(reported and confirmed presence of cattle in the vicinity of the
household), and baseline prevalence estimates of active trachoma
for each study site.
Statistical analysis
Statistical analysis was conducted using Stata 8.2 (Stata
Corporation, College Station, Texas). Descriptive statistics were
used to examine the sample characteristics, prevalence of active
trachoma signs, prevalence of A,F,E interventions, and other
explanatory variables. Differences in proportions were compared
by chi-square test. To investigate the association between severity of
active trachoma signs and A,F,E interventions, ordinal logistic
hierarchical regression models were developed using generalized
linear models (GLM) [22]. The multilevel structure of GLM allowed
for non-independence of the household and district variables,
enabled clustering of individual observations within households, and
districts, and allowed for variability at individual, household, village
and district levels. We fitted an ordinal logistic regression model to
study associations between severity of active trachoma signs and
A,F,E interventions [23]. This model allowed for analysis of a
polytomous ordinal response on a set of predictors and computed
odds ratios (OR) of having a more severe active trachoma sign
compared to a lessseveresign.In thismodel TIwas consideredmore
severe than TF, whichis in turn a more severesign of trachoma than
a normal conjunctiva. This method did not assume that TF causes
TI or that the relationship between the three orders (normal, TF
only, and any TI) is linear. Univariate analysis was conducted for
each explanatory variable. Multivariable models were then devel-
oped by stepwise regression analysis for model selection. This
involved starting with a null model then proceeding in a sequential
fashion of adding/deleting explanatory variables if they satisfied the
entry/removal criterion which was set at 5% significance level using
a log-likelihood ratio test. Age and sex were retained in all
multivariable models to control for any potential confounding
effects. Potential effect modification was evaluated by including
Figure 1. Summary of data framework for analysis of association between active trachoma and A, F, E interventions.
AFE=Antibiotics, Facial cleanliness, Environmental improvement. *98 children in 26 households with missing clean face data, and 24 households
(with 57 children) missing household data. **Multiple imputations of missing data.
doi:10.1371/journal.pntd.0000229.g001
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to investigate the effect of missing data by multiple imputations [24].
Ethical consideration
The Sudan Peoples Liberation Movement Secretariat of Health
(SPLM/Health) approved the protocol and clearance to conduct
the surveys was obtained from the local authorities. Verbal
informed consent to participate was sought from the head of the
household, household respondents and parents of children in
accordance with the declaration of Helsinki. Consent for
household interviews and trachoma examination was documented
by interviewers and examiners on the data collection forms.
Personal identifiers were removed from the data set before
analyses were undertaken.
Results
Characteristics of the study population
A total of 25 clusters (villages) and 743 households in four districts
were surveyed (in Tali district an additional cluster was selected due
to insufficient number of households in one of the six primary
clusters). Of the 1,867 children aged 1–9 years examined for
trachoma, 1,712 (91.7%) in 656 (88.3% of 743 surveyed) households
were included in the main analysis (Figure 1). Of the excluded
households, 36 (4.8%) did not have eligible children, 26 (3.5%) had
all eligible children (98) missing data on clean face, whereas 25
households (with 57 children) had missing data on health education
and facewashing frequency. The overallproportion ofchildren aged
1–4 was 47.8%, the overall proportion of boys was 51.0%, and the
mean age [standard deviation (SD)] was 4.9 years (SD=2.5).
Prevalence of active trachoma signs
The overall prevalence of active trachoma severity scores was:
‘‘no TF, no TI’’=64.1%, range by study district (29.7–94.8); ‘‘TF
only’’=23.1%, range (4.7–41.0); and ‘‘any TI’’=12.8%, range
(0.5–35.9) (Table 1).
Prevalence of A,F,E interventions
Table 1 summarises the uptake of A,F,E interventions by study
district. Overall, 53.0% of the eligible children had received at
least one treatment with azithromycin, whereas 62.4% had a clean
face on examination. Among the 706 households with eligible
children: 72.5% reported washing faces of children two or more
times a day; 73.1% had received health education; 44.4%
had water accessible within 30 minutes; and only 6.3% had pit
latrines.
Ordinal logistic regression analysis of associations
between severity of active trachoma signs and A,F,E
interventions
Univariate ordinal logistic regression analysis of the associations
between severity of active trachoma and A,F,E interventions is
shown on Table 2. Factors associated with reduced odds of a more
severe active trachoma sign compared with not having the risk
factor were: older age (5–9 years compared to 1–4 years) [odds
ratio (OR)=0.3; 95% confidence interval (CI) (0.5–0.9)]; female
sex (OR=0.7; 95% CI 0.5–0.9); azithromycin treatment (one,
two, or three treatments compared with no treatments) (p-
trend,0.001); clean face (OR=0.2; 95% CI 0.1–0.2); increased
frequency of face washing (twice or more frequent daily face
washing compared to once) (p-trend=0.001); and pit latrine
(OR=0.4; 95% CI 0.2–0.9). There was no association between
active trachoma severity and health education, and water access.
Cattle ownership was associated with increased relative odds of a
more severe active trachoma sign; however, this was not
statistically significant: OR=1.4; 95% CI (1.0–2.1); p=0.066.
Table 3 shows the multivariable associations between active
trachoma signs and A,F,E interventions adjusting for age, sex and
baseline prevalence. The number of individual treatments with
azithromycin was associated with reduced relative odds of having
less severe active trachoma (p-trend=0.036). Having received one
or two treatments was associated with a 20% reduction in the
relative odds of active trachoma; however, this was not statistically
significant. Receiving three treatments was independently and
strongly associated with reduction on the relative odds of active
trachoma: OR=0.1; 95% CI (0.0–0.7). Clean face was also
strongly associated with independent reduction in the relative odds
of active trachoma: OR=0.3; 95% CI (0.2–0.4). Reports of
washing faces of children two or more times was independently
associated with reduced relative odds of active trachoma (p-
trend=0.001); whereas households using pit latrines had 60%
reduction in relative odds of active trachoma: OR=0.4; 95% CI
(0.2–0.9). There was no evidence of interaction between the A,F,E
interventions based on our effect modification models. Sensitivity
analysis of the effect of missing data by multiple imputation of
missing data and analysis of association between severity of active
trachoma and A,F,E interventions revealed effect estimates similar
to those in which missing data had been excluded (data not
shown).
Discussion
We have previously published findings on the effects of three
years of the SAFE strategy in Southern Sudan based on a before-
and-after analysis comparing change in prevalence of active
trachoma signs at baseline compared to the three-year evaluation;
which suggested that where more A,F,E activities had been
implemented, greater declines in prevalence were observed [8]. In
this study we present a cross-sectional analysis of associations
between active trachoma and A,F,E components of the SAFE
strategy. The cross-sectional nature of our data had limitations in
that it did not take into account all the baseline risk factors
that may influence the outcome. Modelling associations between
change in prevalence of active trachoma and interventions
accounting for change in risk factors would yield more precise
results. However, this would not have been possible since
the triennial evaluation was not designed to measure change in
risk factors. Further research for a more rigorous method of
modelling the effect of A,F,E interventions using cross-sectional
survey data accounting for change in potential risk factors is
suggested.
Despite the limitations in the study design, our findings suggest
that receiving three treatments with azithromycin, clean face,
increased frequency of washing faces of children and use of pit
latrines were independently associated with reduced prevalence of
active trachoma. The A,F,E interventions are designed to reduce
the risk of trachomatous inflammation in individuals and
communities; leading to a reduction in the lifetime risk of
conjunctival scarring and blinding complications of trachoma.
The effect estimates are consistent with independent effects of
A,F,E interventions and reinforce the argument for implementing
the full SAFE strategy as an integrated approach to control
blinding trachoma. The packaging of trachoma control interven-
tions into a four-pronged community-based approach provides a
comprehensive programme for trachoma elimination that is
adaptable to many different situations and which can be
Association between Active Trachoma and A,F,E
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the SAFE strategy uses appropriate and readily adaptable
technologies, trachoma control can be integrated with broader
health and development efforts targeting poor and marginalized
populations [25].
Our survey was designed as an evaluation of the SAFE strategy
under operational field conditions. We used clinical signs of active
trachoma as operational outcome measures and maintained a high
inter-observer reliability to minimize bias among trachoma
graders, as recommended by the WHO [26]. It has been argued
that nucleic acid amplification techniques (NAATs) of conjunctival
swabs are the best way of determining the prevalence of ocular
chlamydial infection in order to monitoring mass antibiotic
administration [27]; however, this is currently not advocated by
the WHO for programmatic use. We measured health education,
face washing, and azithromycin treatment based on self-reports by
the female heads of households and caregivers of children.
Reporting of face washing behaviour by mothers or caregivers of
children was likely to be overestimated since in most cultures
hygiene is considered a desirable activity regardless of the actual
practices [28]. However, recall bias in reporting of azithromycin
treatment in children by caregivers was likely to underestimate
azithromycin usage to a large extent. While the magnitude of these
biases cannot be estimated, our study showed independent
associations of antibiotics treatment, clean face, face washing
and pit latrines and lower prevalence of active trachoma signs. Use
of multilevel models controlled for clustering and variability of our
observations at the household, village and district levels as well as
the potential confounding effects of age, sex and baseline district
prevalence of active trachoma.
Table 1. Demographic characteristics of sample population, prevalence of active trachoma signs and prevalence of explanatory
variables.
Factor District Overall
Kiech Kuon Padak Katigiri Tali
Children aged 1–9 years examined 574 464 415 414 1,867
Children included in analysis 485 456 381 390 1,712
Prevalence of active trachoma signs (%)
Active trachoma TF and / or TI 70.3 50.0 5.3 6.4 35.9
Trachoma severity score No TF, no TI 29.7 50.0 94.8 93.6 64.1
TF Only 34.4 41.0 4.7 5.9 23.1
Any TI 35.9 9.0 0.5 0.5 12.8
Individual characteristics (%)
Age group 1–4 years 47.6 50.2 42.5 50.3 47.8
5–9 years 52.4 49.8 57.5 49.7 52.2
Sex Male 50.5 53.7 53.8 45.6 51.0
Female 49.5 46.3 46.2 54.4 49.0
Azithromycin treatment None 90.5 28.3 22.6 38.5 47.0
1 time 4.1 42.1 42.5 39.2 30.8
2 times 3.3 29.6 29.4 20.3 20.0
3 times 2.1 0.0 5.5 2.1 2.3
Children with clean faces (%) 44.7 41.2 95.3 77.2 62.4
Number of households include in analysis 184 172 170 180 706
Household characteristics (%)
Face washing frequency per day 1 time or none 25.8 26.5 20.7 37.2 27.5
2 times 51.8 42.8 46.5 41.3 45.8
3 or more times 22.5 30.7 32.8 21.5 26.8
Health education No 50.3 9.9 23.1 21.3 26.9
Yes 49.7 90.1 76.9 78.7 73.1
Water access Less than 30 minutes 65.2 20.6 44.9 45.9 44.4
More than 30 minutes 34.8 79.4 55.1 54.1 55.6
Pit latrine No 98.1 92.5 85.3 98.0 93.8
Yes 1.9 7.5 14.7 2.1 6.3
Cattle ownership No 17.7 55.7 89.8 81.3 58.4
Yes 82.3 44.3 10.2 18.7 41.7
Site characteristics
Baseline prevalence (TF and/or TI)* 81.0 68.0 52.0 74.0 70.0
TF, trachomatous inflammation-follicular; TI, trachomatous inflammation-intense
*Derived from the baseline survey [17]
doi:10.1371/journal.pntd.0000229.t001
Association between Active Trachoma and A,F,E
www.plosntds.org 5 April 2008 | Volume 2 | Issue 4 | e229We defined a clean face as the absence of ocular and or nasal
discharge. Face washing has been shown to be effective in
improving facial cleanliness in children [3]. Having a clean face is
though to reduce autoinfection with ocular Chlamydia as well as
reducing transmission to others. However, active trachoma also
causes ocular and nasal discharge; therefore it is unclear whether
dirty faces lead to trachoma, or trachoma results in dirty faces,
especially in cross-sectional studies [29]. Consistent with previous
studies [30], our models showed that a clean face was
independently associated with lower prevalence of active tracho-
ma. We also found face washing two or more times a day to be
independently associated with lower prevalence of active tracho-
ma. Nonetheless, there was no evidence of statistical interaction
between face washing and cleans faces and between the A,F,E
interventions, possibly because our sample was not powered to
investigate such interactions. Overall, our study suggests that
children who lived in families that were more amenable to
receiving mass distribution of azithromycin, owned a pit latrine,
and had faces washed two or more times a day, were less likely to
have active trachoma.
Previous studies have explored the relationship between active
trachoma and interventions based on ecological analysis [31–34].
However, ecological analyses have a major limitation since bias
may result by generalisation of correlation of observations made at
a group level to individuals. Our study has advantages since we
have modelled individual outcomes of active trachoma. The
ordinal category of active trachoma severity is more precise than
the conventional dichotomous approach since it makes full use of
Table 2. Univariable ordinal logistic regression analysis of association between severity of active trachoma (no TF, no TI; TF only;
any TI) and A,F,E interventions.
Factors No. of Children (n=1,7,12) Prevalence (%) Odds Ratio 95% CI p-value
No TF, no TI TF Only Any TI
Age group (years)
1–4 818 56% 27% 17% 1.0
5–9 894 71% 19% 9% 0.3 0.2–0.4 ,0.001
Sex
Male 873 62% 24% 14% 1.0
Female 839 67% 22% 11% 0.7 0.5–0.9 0.007
Antibiotics
Azithromycin treatment
None 804 49% 29% 22% 1.0 p-trend ,0.001
1 time 527 76% 18% 5% 0.8 0.5–1.0
2 times 342 78% 18% 4% 0.5 0.3–0.8
3 times 39 90% 8% 3% 0.1 0.0–0.4
Facial cleanliness
Clean face
No 643 36% 40% 24% 1.0
Yes 1069 81% 13% 6% 0.2 0.1–0.2 ,0.001
Face washing per day
1 time or none 470 62% 20% 17% 1.0 p-trend=0.001
2 times 784 62% 24% 14% 0.7 0.4–1.0
3 or more times 458 69% 24% 6% 0.5 0.3–0.7
Health education
No 460 56% 25% 19% 1.0
Yes 1252 67% 22% 10% 1.2 0.8–1.8 0.348
Environmental improvement
Water access
#30 minutes 760 62% 20% 18% 1.0
.30 minutes 952 66% 26% 9% 1.1 0.9–1.4 0.178
Pit Latrine
No 1605 63% 24% 13% 1.0
Yes 107 82% 15% 3% 0.4 0.2–0.9 0.038
Cattle ownership
No 999 79% 16% 5% 1.0
Yes 713 44% 33% 24% 1.4 1.0–2.1 0.066
AFE=Antibiotics, Facial cleanliness, Environmental improvement
TF, trachomatous inflammation-follicular; TI, trachomatous inflammation-intense
doi:10.1371/journal.pntd.0000229.t002
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simplified grading scheme. Variability in characteristics across the
study districts has previously been highlighted as a possible
explanation for heterogeneity in uptake of SAFE and therefore
likely to affect the effectiveness of SAFE [8]. We used multilevel
models which allowed for variability at individual, households and
district levels as well as adjustment for non-independence of
observations at household and district levels (clustering).
Conclusions
This study of associations between the A,F,E components of
SAFE and active trachoma showed independent protective effects
against active trachoma of mass systemic azithromycin treatment,
clean face on examination, reported face washing, and presence
and use of pit latrines in the household. This study provides
important evidence for continued advocacy for implementation of
the full SAFE strategy for trachoma control.
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Table 3. Multivariable ordinal logistic regression analysis of
association between severity of active trachoma (no TF, no TI;
TF only; any TI) and A,F,E interventions (n=17,12).
Factor
Odds
Ratio* 95% CI p-value
Antibiotics (azithromycin treatment)
1 time 0.8 0.5–1.1 p-trend=0.036
2 times 0.8 0.5–1.4
3 times 0.1 0.0–0.7
Facial cleanliness
Clean face 0.3 0.2–0.4 ,0.001
Face washing per day (twice) 0.7 0.4–1.0 p-trend=0.001
Face washing per day (thrice or more) 0.4 0.3–0.7
Environmental improvement
Pit latrine 0.4 0.2–0.9 0.031
*Adjusted for the effects of age, sex and baseline prevalence
doi:10.1371/journal.pntd.0000229.t003
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